Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
about
Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease managementInflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple SclerosisMonitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging.Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.The role of MRI in the evaluation of secondary progressive multiple sclerosis.Dietary Inflammatory Index and Risk of Multiple Sclerosis in a Case-Control Study from Iran.The promise of metabolic phenotyping in gastroenterology and hepatology.Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.Prolonged White Matter Inflammation After Cardiopulmonary Bypass and Circulatory Arrest in a Juvenile Porcine Model.Layered genetic control of DNA methylation and gene expression: a locus of multiple sclerosis in healthy individuals.Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosisReduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelinationPharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.Harnessing the integrated stress response for the treatment of multiple sclerosis.Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination.Sodium MRI in Multiple Sclerosis is Compatible with Intracellular Sodium Accumulation and Inflammation-Induced Hyper-Cellularity of Acute Brain Lesions.Immune cell-specific transcriptional profiling highlights distinct molecular pathways controlled by Tob1 upon experimental autoimmune encephalomyelitisBrain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis.The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic ApproachesAbsence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis.Association between the CD24 Ala57Val polymorphism and risk for multiple sclerosis and systemic lupus erythematosus: a meta-analysis.Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.Virtual Reality in Health System: Beyond Entertainment. A Mini-Review on the Efficacy of VR During Cancer Treatment.Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.Cost-effectiveness analysis of ocrelizumab versus subcutaneous interferon beta-1a for the treatment of relapsing multiple sclerosis.The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.Imaging in multiple sclerosis: A new spin on lesions.Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis.Potassium channel expression and function in microglia: Plasticity and possible species variations.Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosisUnprovoked seizures in multiple sclerosis: Why are they rare?Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.Sex Bias in Pathogenesis of Autoimmune Neuroinflammation: Relevance for Dimethyl Fumarate Immunomodulatory/Anti-oxidant Action.Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactomeSerum Neuroinflammatory Disease-Induced Central Nervous System Proteins Predict Clinical Onset of Experimental Autoimmune Encephalomyelitis.
P2860
Q26796643-8C9585FC-E49A-4AC5-9967-E072506EA5CBQ28080754-E1390B7D-B261-4738-A49E-7770F96196BEQ30827515-55E0915E-69F5-4E91-8609-C06E420312EDQ30871249-3DB90473-53D3-43AF-88F0-2E43001A5CE7Q31033345-33604798-D448-4EFD-9349-B9B062E94E7CQ33788949-6F8359DB-C846-42C5-9BAC-8E6F8079D3D0Q35701279-34BB38C1-CD4D-48A3-882F-5FF5BF93A45AQ35853077-7EA10ECE-33DC-4402-831A-ADDF45721AF1Q36053181-DE39210E-ADCA-4F4A-9037-1AB0828B0A17Q36089373-030F3463-2F40-4F87-B664-F8AA794D9C36Q36186773-9315C3F3-F746-4FEC-BCCD-9DFF4A5855C7Q36276516-653C00DA-3D76-4A8F-8A7A-51A1D1A264BEQ36344854-B1F9E60E-5FB3-4CB4-A3BB-C949AA62C388Q36353053-541BFD43-BDCC-4071-A4A3-B5A71796D959Q36398055-A4DE1D27-490D-432A-97E4-0C3207794A9BQ36689566-4EBF9B11-953F-40F8-8F1A-4F3B77528B24Q36768701-E8A2DAE6-B13E-4C9A-B4C0-55C4203E0BE9Q37163249-83ABAE6F-F823-40E3-BA2C-2236CEB00B30Q37193174-C11165F9-0276-47BD-A6AD-DF7ACCEF2195Q37444374-F933CB8C-EE38-4340-A303-C5ADFB94EE7BQ37459099-1DBD6E41-3547-4C72-BA39-77D5EFE2C9D0Q37548170-5A474072-C73C-4575-80A5-2D0B88FDCE9DQ37586538-930C7E4B-1BAE-4AB0-970D-F789D1380AE3Q37738700-E682DAF6-7C53-40AF-98BE-7A6D0773E72FQ38374295-7C021202-9D67-442F-82F0-368C19228352Q38560105-9B09D393-BAAA-4E78-A3F7-23577DAEE2BDQ38609231-2F955E26-B68D-4FAB-A105-850446722EC1Q38639337-2D865E63-A772-418D-A601-A6A51FD5E252Q38681227-8A21B49F-9413-4BA7-A23B-7472D5263711Q38767477-9E30F1B3-078D-497A-9A43-A7EE35ECAFFCQ38910256-B145345E-16E5-43D4-BF45-7D95BFCE9596Q38911206-2A95C080-5C28-4815-A803-E2FE2E80CB86Q38917772-628CD6B1-BC9E-46DA-9308-A730A2A037DEQ39448667-85DDD849-DA6C-455C-90CE-18B0A8D79759Q39449276-502E4B6E-D1E3-4FD0-B0E0-9F04DBCABD3AQ39777527-C62BE715-CFCF-403D-8487-A245582F8F1CQ40189763-09AC3467-3B79-4B12-824D-5AA41AA7D279Q40749948-48F23E9F-A129-4E8B-AB53-D93DCEFEAABFQ40991982-7E89BABD-22B6-4012-8FE6-FEB6E0E739F2Q41026569-FB000139-37BF-42A7-B241-F694D5749694
P2860
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
@ast
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
@en
type
label
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
@ast
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
@en
prefLabel
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
@ast
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
@en
P2093
P50
P1433
P1476
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
@en
P2093
Benedetta Bodini
Bruno Stankoff
Claudia A M Wheeler-Kingshott
Daniel Pelletier
David H Miller
Olga Ciccarelli
Petra J W Pouwels
Seth A Smith
Tarek Yousry
P304
P356
10.1016/S1474-4422(14)70101-2
P577
2014-07-06T00:00:00Z